Cytek Biosciences, Inc.CTKBNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+12.1%
5Y CAGR+30.6%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+12.1%/yr
Annual compound
5Y CAGR
+30.6%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
3.8x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $144.84M | +10.0% |
| 2024 | $131.63M | -4.1% |
| 2023 | $137.27M | +33.6% |
| 2022 | $102.78M | +46.9% |
| 2021 | $69.99M | +83.9% |
| 2020 | $38.05M | -17.2% |
| 2019 | $45.93M | - |